(Q35328171)

7 August 2017

1 reference

title

Unravelling the genomic targets of small molecules using high-throughput sequencing (English)

1 reference

high-throughput sequencing

7 August 2017

main subject

1 reference

Raphaël Rodriguez

1

0 references

author name string

Kyle M Miller

series ordinal

2

1 reference

7 August 2017

publication date

14 October 2014

1 reference

7 August 2017

published in

Nature Reviews Genetics

1 reference

7 August 2017

volume

15

1 reference

7 August 2017

issue

12

1 reference

7 August 2017

page(s)

783-796

1 reference

Histones: annotating chromatin

7 August 2017

cites work

1 reference

Chromatin Structure: A Repeating Unit of Histones and DNA

21 January 2018

1 reference

Determinants and dynamics of genome accessibility

21 January 2018

1 reference

Functions of DNA methylation: islands, start sites, gene bodies and beyond

21 January 2018

1 reference

Chromatin modifications and their function

21 January 2018

1 reference

Histone H4-K16 acetylation controls chromatin structure and protein interactions

21 January 2018

1 reference

Epigenetic protein families: a new frontier for drug discovery

21 January 2018

1 reference

Perceiving the epigenetic landscape through histone readers.

21 January 2018

1 reference

Chromatin structure and the inheritance of epigenetic information

21 January 2018

1 reference

Molecular recognition of DNA by small molecules

21 January 2018

1 reference

Cancer epigenetics: from mechanism to therapy

21 January 2018

1 reference

Targeting epigenetic readers in cancer.

21 January 2018

1 reference

Chromatin proteins and modifications as drug targets

21 January 2018

1 reference

Charting histone modifications and the functional organization of mammalian genomes

21 January 2018

1 reference

The next-generation sequencing revolution and its impact on genomics

21 January 2018

1 reference

High-resolution profiling of histone methylations in the human genome

21 January 2018

1 reference

Genome-wide mapping of in vivo protein-DNA interactions

21 January 2018

1 reference

Genome-wide maps of chromatin state in pluripotent and lineage-committed cells

21 January 2018

1 reference

A decade of exploring the cancer epigenome - biological and translational implications

21 January 2018

1 reference

An integrated encyclopedia of DNA elements in the human genome

21 January 2018

1 reference

Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer

21 January 2018

1 reference

From histones to RNA: role of methylation in cancer

21 January 2018

1 reference

Genome-wide localization of small molecules

21 January 2018

1 reference

Histone methylation: a dynamic mark in health, disease and inheritance

21 January 2018

1 reference

Epigenetic inheritance during the cell cycle

21 January 2018

1 reference

Every amino acid matters: essential contributions of histone variants to mammalian development and disease

21 January 2018

1 reference

Long non-coding RNAs: insights into functions

21 January 2018

1 reference

Human telomere, oncogenic promoter and 5'-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics

21 January 2018

1 reference

DNA sequences that interfere with transcription: implications for genome function and stability.

21 January 2018

1 reference

Epigenetic therapy of cancer: past, present and future

21 January 2018

1 reference

Histone deacetylase inhibitors: anticancer compounds

21 January 2018

1 reference

Epigenetic modifications as therapeutic targets

21 January 2018

1 reference

ChIP-seq and beyond: new and improved methodologies to detect and characterize protein-DNA interactions

21 January 2018

1 reference

The molecular origin of DNA-drug specificity in netropsin and distamycin

21 January 2018

1 reference

Design of sequence-specific DNA-binding molecules

21 January 2018

1 reference

Regulation of gene expression by small molecules

21 January 2018

1 reference

Guiding the design of synthetic DNA-binding molecules with massively parallel sequencing

21 January 2018

1 reference

Prevalence of quadruplexes in the human genome

21 January 2018

1 reference

G-quadruplex structures: in vivo evidence and function

21 January 2018

1 reference

DNA secondary structures: stability and function of G-quadruplex structures

21 January 2018

1 reference

21 January 2018

1 reference

Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?

21 January 2018

1 reference

Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription

21 January 2018

1 reference

A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres

21 January 2018

1 reference

Small-molecule-induced DNA damage identifies alternative DNA structures in human genes

21 January 2018

1 reference

Small-molecule-mediated G-quadruplex isolation from human cells

21 January 2018

1 reference

A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes

21 January 2018

1 reference

Targeting DNA topoisomerase II in cancer chemotherapy

21 January 2018

1 reference

The DNA-damage response in human biology and disease

21 January 2018

1 reference

Genome-wide kinetics of nucleosome turnover determined by metabolic labeling of histones

21 January 2018

1 reference

A map of open chromatin in human pancreatic islets

21 January 2018

1 reference

Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin

21 January 2018

1 reference

Doxorubicin enhances nucleosome turnover around promoters

21 January 2018

1 reference

Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.

21 January 2018

1 reference

Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements

21 January 2018

1 reference

Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity

21 January 2018

1 reference

BAF complexes facilitate decatenation of DNA by topoisomerase IIα

21 January 2018

1 reference

Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes

21 January 2018

1 reference

Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons

21 January 2018

1 reference

Topoisomerases facilitate transcription of long genes linked to autism

21 January 2018

1 reference

Nucleotide deficiency promotes genomic instability in early stages of cancer development

21 January 2018

1 reference

Replication stress links structural and numerical cancer chromosomal instability

21 January 2018

1 reference

Identification of early replicating fragile sites that contribute to genome instability

21 January 2018

1 reference

Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing

21 January 2018

1 reference

The emerging roles of forkhead box (Fox) proteins in cancer

21 January 2018

1 reference

The transcription factor FOXM1 is a cellular target of the natural product thiostrepton

21 January 2018

1 reference

Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells

21 January 2018

1 reference

The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism.

21 January 2018

1 reference

The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members

21 January 2018

1 reference

Epigenetic therapies in MDS and AML

21 January 2018

1 reference

Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines

21 January 2018

1 reference

Functional DNA demethylation is accompanied by chromatin accessibility

21 January 2018

1 reference

Histone deacetylases and cancer

21 January 2018

1 reference

Mammalian DNA repair: HATs and HDACs make their mark through histone acetylation

21 January 2018

1 reference

Inhibition of histone deacetylation: a strategy for tumor radiosensitization

21 January 2018

1 reference

Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining

21 January 2018

1 reference

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

21 January 2018

1 reference

Combination therapy with vidaza and entinostat suppresses tumor growth and reprograms the epigenome in an orthotopic lung cancer model

21 January 2018

1 reference

hDOT1L links histone methylation to leukemogenesis

21 January 2018

1 reference

Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.

21 January 2018

1 reference

MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.

21 January 2018

1 reference

Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia

21 January 2018

1 reference

Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemia

21 January 2018

1 reference

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

21 January 2018

1 reference

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

21 January 2018

1 reference

Analysis of the coding genome of diffuse large B-cell lymphoma

21 January 2018

1 reference

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

21 January 2018

1 reference

Selective inhibition of BET bromodomains

21 January 2018

1 reference

Suppression of inflammation by a synthetic histone mimic

21 January 2018

1 reference

Discovery and characterization of small molecule inhibitors of the BET family bromodomains

21 January 2018

1 reference

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

21 January 2018

1 reference

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

21 January 2018

1 reference

Targeting MYC dependence in cancer by inhibiting BET bromodomains

21 January 2018

1 reference

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

21 January 2018

1 reference

Super-enhancers in the control of cell identity and disease

21 January 2018

1 reference

Master transcription factors and mediator establish super-enhancers at key cell identity genes

21 January 2018

1 reference

Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.

21 January 2018

1 reference

Selective inhibition of tumor oncogenes by disruption of super-enhancers

21 January 2018

1 reference

Small-molecule inhibition of BRDT for male contraception

21 January 2018

1 reference

Chem-seq permits identification of genomic targets of drugs against androgen receptor regulation selected by functional phenotypic screens

21 January 2018

1 reference

Chemical inhibition of NAT10 corrects defects of laminopathic cells

21 January 2018

1 reference

Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents.

21 January 2018

1 reference

JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin

21 January 2018

1 reference

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

21 January 2018

1 reference

Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries

21 January 2018

1 reference

An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1

21 January 2018

1 reference

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

21 January 2018

1 reference

Topoisomerase I inhibitors: camptothecins and beyond

21 January 2018

1 reference

Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress

21 January 2018

1 reference

A small molecule inhibitor of the BLM helicase modulates chromosome stability in human cells

21 January 2018

1 reference

Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth.

21 January 2018

1 reference

Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor

21 January 2018

1 reference

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.

21 January 2018

1 reference

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

21 January 2018

1 reference

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

Self-renewal as a therapeutic target in human colorectal cancer.

21 January 2018

1 reference

Nucleosome acidic patch promotes RNF168- and RING1B/BMI1-dependent H2AX and H2A ubiquitination and DNA damage signaling.

21 January 2018

1 reference

A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response

21 January 2018

1 reference

Selective and cell-active inhibitors of the USP1/ UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells

21 January 2018

1 reference

Identification and characterization of small molecule inhibitors of a plant homeodomain finger

21 January 2018

1 reference

Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option

21 January 2018

1 reference

Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases.

21 January 2018

1 reference

G-quadruplexes: selective DNA targeting for cancer therapeutics?

21 January 2018

1 reference

Myelodysplastic syndromes.

31 March 2020

1 reference

Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker

31 March 2020

1 reference

A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth

31 March 2020

1 reference

Click Chemistry: Diverse Chemical Function from a Few Good Reactions

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25311424

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25311424

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRG3796

1 reference

7 August 2017

1 reference